ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹157 Cr | ₹142 Cr | ₹141 Cr | ₹140 Cr | ₹122 Cr |
What is the latest Cash Flow from Operating Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹157 Cr |
| Mar2025 | ₹142 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹122 Cr |
How is Cash Flow from Operating Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹157 Cr | 10.02 | |
| Mar2025 | ₹142 Cr | 0.80 | |
| Mar2024 | ₹141 Cr | 0.72 | |
| Mar2023 | ₹140 Cr | 14.78 | |
| Mar2022 | ₹122 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,293.4 Cr | -1.1% | -2.3% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -1.1% |
-2.3% |
-12.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses